Skip to content
Menu

BMO Capital Maintains Outperform on BrightSpring Health, Raises Price Target to $84

Benzinga Newsdesk 2 days ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

BMO Capital analyst Sean Dodge maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $80 to $84.

BMO Capital analyst Sean Dodge maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $80 to $84.

Read at benzinga.com